Genpact Ltd. (G) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1109033,
    "name": "Genpact Ltd.",
    "stock_name": "Genpact Ltd.",
    "full_name": "Genpact Ltd.",
    "name_url": "stocks-analysis/genpact",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "46.01",
    "chg": 0.81,
    "chgp": "1.79%",
    "dir": 1,
    "prev_price": "45.20",
    "mcapval": "7,758.72",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "BMG3922B1072",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "3.89 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/genpact-1109033-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Genpact Ltd. Hits Day High with 15.89% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpact-ltd-hits-day-high-with-1589-surge-in-stock-price-3686547",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpact_priceRelatedfactors_3686547.png",
        "date": "2025-11-10 17:49:38",
        "description": "Genpact Ltd. saw a notable rise in its stock price on November 7, 2025, reaching an intraday high. The company has demonstrated strong short-term performance, although it has underperformed compared to the S&P 500 over the past year. Genpact maintains solid financial metrics, including high management efficiency and low debt levels."
      },
      {
        "title": "Genpact Stock Plummets to New 52-Week Low at $37.50",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpact-stock-plummets-to-new-52-week-low-at-3750-3671493",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Genpact_priceRelatedfactors_3671493.png",
        "date": "2025-11-04 17:52:59",
        "description": "Genpact has hit a new 52-week low of USD 37.50, reflecting a notable decline in its performance compared to the S&P 500. The company, with a market cap of USD 7,759 million, shows a low debt-to-equity ratio and high management efficiency, but its net profit has decreased significantly."
      },
      {
        "title": "Genpact Stock Plummets to 52-Week Low at USD 37.77",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpact-stock-plummets-to-52-week-low-at-usd-3777-3659123",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/Genpact_priceRelatedfactors_3659123.png",
        "date": "2025-10-30 18:32:41",
        "description": "Genpact has reached a new 52-week low, trading at USD 37.77, reflecting a notable decline for the small-cap company. Despite a low debt-to-equity ratio and strong management efficiency, its net profit has decreased significantly. The stock is trading at a discount compared to historical valuations."
      },
      {
        "title": "Is Genpact Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-genpact-ltd-overvalued-or-undervalued-3637623",
        "imagepath": "",
        "date": "2025-10-21 12:05:56",
        "description": "As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. has a P/E of 15.81, suggesting that Genpact is positioned competitively within its industry.\n\nDespite its fair valuation, Genpact has underperformed against the S&P 500 in various timeframes, particularly over the last three years, where it returned -12.78% compared to the S&P 500's 81.19%. This underperformance may indicate that while the stock is fairly valued, it may not be the best investment opportunity relative to broader market performance...."
      },
      {
        "title": "Genpact Ltd. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpact-ltd-sees-valuation-grade-downgrade-from-attractive-to-fair-amidst-lower-returns-3640351",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/Genpact_valuationdot_3640351.png",
        "date": "2025-10-20 15:11:04",
        "description": "Genpact Ltd. has recently adjusted its valuation, with its stock price at $39.44. Over the past year, it has achieved a 2.49% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 14, an EV to EBITDA ratio of 10.29, and a notable dividend yield of 150.00%."
      },
      {
        "title": "Is Genpact Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-genpact-ltd-overvalued-or-undervalued-3634493",
        "imagepath": "",
        "date": "2025-10-20 12:23:26",
        "description": "As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. stands at 15.81, suggesting that Genpact is competitively priced within its industry.\n\nDespite its fair valuation, Genpact has underperformed relative to the S&P 500, with a year-to-date return of -8.17% compared to the index's 13.30%. This trend continues over longer periods, with a 3-year return of -12.78% versus 81.19% for the S&P 500, highlighting potential concerns regarding its growth prospects...."
      },
      {
        "title": "Is Genpact Ltd. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-genpact-ltd-overvalued-or-undervalued-3632032",
        "imagepath": "",
        "date": "2025-10-19 12:00:58",
        "description": "As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 14, while the EV to EBITDA ratio is 10.29, and the Price to Book Value is 3.09. In comparison, peers such as ICON plc and Booz Allen Hamilton Holding Corp. have P/E ratios of 14.64 and 15.81, respectively, suggesting that Genpact is positioned competitively within its industry.\n\nDespite its fair valuation, Genpact has struggled in terms of stock performance, with a year-to-date return of -8.17%, significantly underperforming the S&P 500's return of 13.30% over the same period. This trend is further highlighted by a 3-year return of -12.78% compared to the S&P 500's impressive 81.19%, reinforcing the notion that while the stock may be fairly valued, it has not delivered strong re..."
      },
      {
        "title": "Genpact Ltd. Experiences Revision in Its Stock Evaluation Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/genpact-ltd-technical-trend-changes-from-mildly-bearish-to-bearish-amid-declining-performance-3600777",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/Genpact_technicaldot_3600777.png",
        "date": "2025-10-07 19:08:32",
        "description": "Genpact Ltd. has recently adjusted its technical trends, with its current price slightly lower than the previous close. Over the past year, the company has underperformed compared to the S&P 500. Various technical indicators suggest a predominantly bearish outlook, reflecting ongoing challenges in the market."
      },
      {
        "title": "Is Genpact Ltd. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-genpact-ltd-technically-bullish-or-bearish-3598999",
        "imagepath": "",
        "date": "2025-10-07 12:15:41",
        "description": "As of 3 October 2025, the technical trend for Genpact Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators such as the MACD on a weekly basis indicating bearish momentum, and moving averages also reflecting a bearish outlook. Bollinger Bands confirm a bearish trend in both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is bullish on the monthly, which contrasts with the overall bearish sentiment. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a 1-week return of -2.51% compared to the S&P 500's 1.09%, and a year-to-date return of -4.28% against the S&P 500's 14.18%...."
      }
    ],
    "total": 18,
    "sid": "1109033",
    "stock_news_url": "https://www.marketsmojo.com/news/genpact-1109033"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Genpact Ltd. Hits Day High with 15.89% Surge in Stock Price

2025-11-10 17:49:38

Genpact Ltd. saw a notable rise in its stock price on November 7, 2025, reaching an intraday high. The company has demonstrated strong short-term performance, although it has underperformed compared to the S&P 500 over the past year. Genpact maintains solid financial metrics, including high management efficiency and low debt levels.

Genpact Stock Plummets to New 52-Week Low at $37.50

2025-11-04 17:52:59

Genpact has hit a new 52-week low of USD 37.50, reflecting a notable decline in its performance compared to the S&P 500. The company, with a market cap of USD 7,759 million, shows a low debt-to-equity ratio and high management efficiency, but its net profit has decreased significantly.

Genpact Stock Plummets to 52-Week Low at USD 37.77

2025-10-30 18:32:41

Genpact has reached a new 52-week low, trading at USD 37.77, reflecting a notable decline for the small-cap company. Despite a low debt-to-equity ratio and strong management efficiency, its net profit has decreased significantly. The stock is trading at a discount compared to historical valuations.

Is Genpact Ltd. overvalued or undervalued?

2025-10-21 12:05:56

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued based on its current metrics, with a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. has a P/E of 15.81, suggesting that Genpact is positioned competitively within its industry. Despite its fair valuation, Genpact has underperformed against the S&P 500 in various timeframes, particularly over the last three years, where it returned -12.78% compared to the S&P 500's 81.19%. This underperformance may indicate that while the stock is fairly valued, it may not be the best investment opportunity relative to broader market performance....

Genpact Ltd. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics

2025-10-20 15:11:04

Genpact Ltd. has recently adjusted its valuation, with its stock price at $39.44. Over the past year, it has achieved a 2.49% return, lagging behind the S&P 500. Key metrics include a P/E ratio of 14, an EV to EBITDA ratio of 10.29, and a notable dividend yield of 150.00%.

Is Genpact Ltd. overvalued or undervalued?

2025-10-20 12:23:26

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. The company appears to be fairly valued at this time. Key valuation ratios include a P/E ratio of 14, an EV to EBITDA of 10.29, and a Price to Book Value of 3.09. In comparison to peers, ICON plc has a P/E of 14.64, while Booz Allen Hamilton Holding Corp. stands at 15.81, suggesting that Genpact is competitively priced within its industry. Despite its fair valuation, Genpact has underperformed relative to the S&P 500, with a year-to-date return of -8.17% compared to the index's 13.30%. This trend continues over longer periods, with a 3-year return of -12.78% versus 81.19% for the S&P 500, highlighting potential concerns regarding its growth prospects....

Is Genpact Ltd. overvalued or undervalued?

2025-10-19 12:00:58

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 14, while the EV to EBITDA ratio is 10.29, and the Price to Book Value is 3.09. In comparison, peers such as ICON plc and Booz Allen Hamilton Holding Corp. have P/E ratios of 14.64 and 15.81, respectively, suggesting that Genpact is positioned competitively within its industry. Despite its fair valuation, Genpact has struggled in terms of stock performance, with a year-to-date return of -8.17%, significantly underperforming the S&P 500's return of 13.30% over the same period. This trend is further highlighted by a 3-year return of -12.78% compared to the S&P 500's impressive 81.19%, reinforcing the notion that while the stock may be fairly valued, it has not delivered strong re...

Genpact Ltd. Experiences Revision in Its Stock Evaluation Amid Market Challenges

2025-10-07 19:08:32

Genpact Ltd. has recently adjusted its technical trends, with its current price slightly lower than the previous close. Over the past year, the company has underperformed compared to the S&P 500. Various technical indicators suggest a predominantly bearish outlook, reflecting ongoing challenges in the market.

Is Genpact Ltd. technically bullish or bearish?

2025-10-07 12:15:41

As of 3 October 2025, the technical trend for Genpact Ltd. has changed from mildly bearish to bearish. The current technical stance is bearish, with key indicators such as the MACD on a weekly basis indicating bearish momentum, and moving averages also reflecting a bearish outlook. Bollinger Bands confirm a bearish trend in both weekly and monthly time frames. The KST shows a mildly bullish signal on the weekly but is bullish on the monthly, which contrasts with the overall bearish sentiment. Additionally, the stock has underperformed against the S&P 500 across multiple periods, with a 1-week return of -2.51% compared to the S&P 500's 1.09%, and a year-to-date return of -4.28% against the S&P 500's 14.18%....

View All News